Αποτελέσματα Αναζήτησης
The authors provide an update on the diagnostic and prog-nostic value of the 5 most common cutaneous abnor-malities associated with COVID-19 in adult patients: morbilliform rash, urticaria, vesicles, pseudo-chilblains, and vaso-occlusive lesions.
A picture gallery of various skin symptoms found in patients with COVID-19 infection (SARS-CoV-2).
Patients with COVID‐19 may present with unusual skin manifestations, including urticarial rashes, vesicular lesions, and chilblains on fingers or toes. For patients presenting with new chilblain lesions of unclear cause, polymerase chain reaction testing for SARS‐CoV‐2 within 7 days of the onset of lesions may be warranted.
16 Δεκ 2020 · Results. We identified 5 skin lesions common in patients with COVID-19: pseudo-chilblains, rashes containing macules and papules, and urticarial, vesicular, and vaso-occlusive lesions.
6 Ιουν 2020 · The primary etiologies include vasculitis versus direct viral involvement. There are several types of skin findings described in association with COVID-19. These include maculopapular rashes, urticaria, vesicles, petechiae, purpura, chilblains, livedo racemosa, and distal limb ischemia.
1 Μαΐ 2021 · Diagnosis of COVID‐19 using skin rashes. Several studies have observed that patients hospitalized with COVID‐19 experienced unusual skin rashes, such as urticaria (‘nettle rash’), chickenpox‐type rash, and reddish and purplish bumps on the fingers or toes.
Vesicular rashes may suggest an initial diagnosis of COVID-19, acral lesions may be most appropriate for epidemiological uses, and vascular rashes may be a useful prognostic marker for severe disease.
